Biosimilars are biopharmaceutical drugs that are molecularly similar with equivalent therapeutic efficacy and safety as compared to corresponding reference biologics. Biosimilars provide a cost-effective alternate to expensive biologics and expand patient access. With patent expiry of large molecular biologics, biosimilars ...